Medical Condition News

RSS

Role of serotonin in autism spectrum disorders

Mouse models are yielding important clues about the nature of autism spectrum disorders, which impact an estimated one in 110 children in the U.S. In labs at the UT Health Science Center San Antonio, researchers are studying strains of mice that inherently mimic the repetitive and socially impaired behaviors present in these disorders.

25 Feb 2011

$MHI begins patient enrollment for new device to treat refractory angina$

MHI begins patient enrollment for new device to treat refractory angina

The interventional cardiology team at the Montreal Heart Institute recently began patient enrolment for a new device, the Neovasc Reducer, designed to treat patients suffering from refractory angina.

25 Feb 2011

Swedish brain scientists create illusion of owning three arms

How we experience our own bodies is a classical question in psychology and neuroscience. It has long been believed that our body image is limited by our innate body plan - in other words that we cannot experience having more than one head, two arms and two legs. However, brain scientists at the Swedish medical university Karolinska Institutet have now shown that it is possible to make healthy volunteers experience having three arms at the same time.

25 Feb 2011

Salix anticipates receipt of FDA's CRL for XIFAXAN 550 mg sNDA

Salix Pharmaceuticals, Ltd. today announced that based on a telephone conversation with the U.S. Food and Drug Administration held last evening, the Company anticipates receiving a Complete Response Letter on or before the March 7, 2011 PDUFA goal date for the supplemental New Drug Application for XIFAXAN 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome and IBS-related bloating.

25 Feb 2011

Experts at ICAO warn about risk of cardiometabolic consequences in overweight individuals

Experts meeting at the 2nd International Congress on Abdominal Obesity today issued a warning that millions of individuals around the globe are at risk from the cardiometabolic consequences of being overweight. Worryingly, the experts suggest that these people are not being identified by their doctors.

25 Feb 2011

Unigene accelerates UGP281 anorexigenic peptide to treat obese patients

Unigene Laboratories, Inc. announced today that the Company is accelerating the development of its lead proprietary anorexigenic peptide, UGP281.

25 Feb 2011

Survey: 72% of locked-in syndrome patients are happy

Most "locked-in syndrome" patients say they are happy, and many of the factors reported by those who say they are unhappy can be improved, suggest the results of the largest survey of its kind, published in the launch issue of the new online journal BMJ Open.

25 Feb 2011

Lux initiates pivotal voclosporin Phase 3 trial in non-infectious uveitis

Isotechnika Pharma Inc. announced today that Lux Biosciences, Inc. has commenced its pivotal Phase 3 trial using voclosporin for the treatment of non-infectious uveitis, a leading cause of vision loss and long-term disability.

25 Feb 2011

Zoledronic acid demonstrates anti-angiogenic effects in metastatic lung cancer

A drug that is currently used to help treat bone metastases in patients with lung cancer could also be useful at an earlier stage of treatment, to prevent the cancer from spreading in the first place, Italian researchers have found.

25 Feb 2011

HRS invites NewCardio to present CardioBip system clinical study results at Annual Scientific Meeting

NewCardio, Inc., a cardiovascular diagnostic solutions developer, announced today that the Company has been invited by the Heart Rhythm Society to present results of a recent clinical study showing that recurrent atrial fibrillation was accurately and timely detected in patients who used CardioBip for daily monitoring following catheter ablation procedures.

25 Feb 2011

New rapid and inexpensive test can effectively identify never-smoking group with lung adenocarcinoma

An inexpensive and rapid testing method can effectively identify a sub-group of never-smoking lung cancer patients whose tumors express a molecule associated with increased risk of disease progression or recurrence, US researchers have found.

25 Feb 2011

Stemline licenses clinically active oncology vaccine for dual targeting of tumor bulk and cancer stem cells

Stemline Therapeutics, Inc., a clinical stage biopharmaceutical company developing novel oncology compounds that target cancer stem cells (CSCs), today announced that it holds the license, from the University of Pittsburgh ("Pitt"), for the exclusive worldwide rights to a clinically active oncology vaccine directed to multiple defined targets on tumor bulk and CSCs.

25 Feb 2011

Omega-3 fish oils: Natural health solution for the heart

Did you know that over the average life span, a heart beats 2 to 3 billion times? As one of the hardest working muscles pumping oxygen and essential nutrients throughout your body an average of 100,000 times a day, the heart needs a lot of help to stay working fit.

25 Feb 2011

BSD announces inclusion of hyperthermia and chemotherapy for high-risk sarcoma cancer patients

BSD Medical Corporation today announced the inclusion of hyperthermia and chemotherapy as a recommended cancer treatment for Stage IV sarcomas in the "Practice Guidelines in Oncology", which is issued by the National Comprehensive Cancer Network.

25 Feb 2011

Study: Rare genetic mutations may provide clues to improve treatment for schizophrenia

Scientists are eyeing a rare genetic glitch for clues to improved treatments for some people with schizophrenia - even though they found the mutation in only one third of 1 percent of patients.

25 Feb 2011

PHA partners with NORD, EURORDIS to raise global awareness about PH

Pulmonary hypertension is a rare, under-diagnosed disease that can strike people at any time, affecting newborns to the elderly or anyone in between. To raise global awareness of this invisible disease, the Pulmonary Hypertension Association is partnering with the National Organization for Rare Disorders and Rare Diseases Europe on Feb. 28, 2011, to observe Rare Disease Day.

25 Feb 2011

Feasibility study to test scalp cooling device in breast cancer patients undergoing chemotherapy

A feasibility study to test the use of a scalp cooling device that breast cancer patients will wear while undergoing chemotherapy treatment will be conducted at Wake Forest University Baptist Medical Center. This will be part of the first significant study of the medical device in the United States.

25 Feb 2011

Researchers to share information on delirium at ADS conference

At least seven million hospitalized Americans suffer from delirium each year, however the condition goes unrecognized in more than 60 percent of patients. Even if diagnosed, there is no effective way to treat the condition, which is a growing concern to medical professionals.

25 Feb 2011

Variation in PSA levels does not predict prostate cancer, may lead to unnecessary biopsies

Researchers at Memorial Sloan-Kettering Cancer Center have found that change in PSA levels over time — known as PSA velocity — is a poor predictor of prostate cancer and may lead to many unnecessary biopsies.

25 Feb 2011

FN-EDA protein can reduce damage after heart attack

Scientists have identified a protein that plays a key role in debilitating changes that occur in the heart after a heart attack, according to research reported in Circulation Research: Journal of the American Heart Association.

25 Feb 2011

Medical Condition News

Role of serotonin in autism spectrum disorders

MHI begins patient enrollment for new device to treat refractory angina

Swedish brain scientists create illusion of owning three arms

Salix anticipates receipt of FDA's CRL for XIFAXAN 550 mg sNDA

Experts at ICAO warn about risk of cardiometabolic consequences in overweight individuals

Unigene accelerates UGP281 anorexigenic peptide to treat obese patients

Survey: 72% of locked-in syndrome patients are happy

Lux initiates pivotal voclosporin Phase 3 trial in non-infectious uveitis

Zoledronic acid demonstrates anti-angiogenic effects in metastatic lung cancer

HRS invites NewCardio to present CardioBip system clinical study results at Annual Scientific Meeting

New rapid and inexpensive test can effectively identify never-smoking group with lung adenocarcinoma

Stemline licenses clinically active oncology vaccine for dual targeting of tumor bulk and cancer stem cells

Omega-3 fish oils: Natural health solution for the heart

BSD announces inclusion of hyperthermia and chemotherapy for high-risk sarcoma cancer patients

Study: Rare genetic mutations may provide clues to improve treatment for schizophrenia

PHA partners with NORD, EURORDIS to raise global awareness about PH

Feasibility study to test scalp cooling device in breast cancer patients undergoing chemotherapy

Researchers to share information on delirium at ADS conference

Variation in PSA levels does not predict prostate cancer, may lead to unnecessary biopsies

FN-EDA protein can reduce damage after heart attack

How Programmable Nanobiology Could Drive the Fifth Industrial Revolution

Dr. Anthony Grice

Building quality into drug development for safer, faster medicines

Latest News